Jiangsu Yahong Meditech Co., Ltd. Class ASSE: 688176

"Jiangsu Asieris Pharmaceuticals Co., Ltd."Announcement on Voluntary Disclosure of the Approval of the Clinical Trial Application for APL-2501 by the National Medical Products Administration

Aug 27, 2026 · Issued by Jiangsu Yahong Meditech Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Voluntary Disclosure of the Approval of the Clinical Trial Application for APL-2501 by the National Medical Products Administration

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Jiangsu Yahong Meditech Co., Ltd. Class A

"JIANGSU YAHONG MEDITECH CO., LTD."Announcement on Voluntary Disclosure of the FDA Approval of the APL-2501 Clinical Trial ApplicationAug 14
"JIANGSU YAHONG MEDITECH CO., LTD."Announcement on Arbitration Progress and Submission of Counter‑claim in ArbitrationAug 6

All Jiangsu Yahong Meditech Co., Ltd. Class A news releases